Abstract

Considerable time and effort has been spent in developing analysis and quality assessment methods to allow the use of microarrays in a clinical setting. As is the case for microarrays and other high-throughput technologies, data from new high-throughput sequencing technologies are subject to technological and biological biases and systematic errors that can impact downstream analyses. Only when these issues can be readily identified and reliably adjusted for will clinical applications of these new technologies be feasible. Although much work remains to be done in this area, we describe consistently observed biases that should be taken into account when analyzing high-throughput sequencing data. In this article, we review current knowledge about these biases, discuss their impact on analysis results, and propose solutions.

Keywords

Computer scienceThroughputData scienceDNA microarrayRisk analysis (engineering)Data miningMedicineBiologyTelecommunicationsGenetics

Affiliated Institutions

Related Publications

Publication Info

Year
2010
Type
editorial
Volume
2
Issue
12
Pages
87-87
Citations
105
Access
Closed

Social Impact

Social media, news, blog, policy document mentions

Citation Metrics

105
OpenAlex
2
Influential
88
CrossRef

Cite This

Margaret A. Taub, Héctor Corrada Bravo, Rafael A. Irizarry (2010). Overcoming bias and systematic errors in next generation sequencing data. Genome Medicine , 2 (12) , 87-87. https://doi.org/10.1186/gm208

Identifiers

DOI
10.1186/gm208
PMID
21144010
PMCID
PMC3025429

Data Quality

Data completeness: 81%